Conflict of interest declaration: Andrew B Jull

Roles in: Wounds Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
No

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Lead author of a trial that has been included in systematic review for which I am the lead author (Honey as topical treatment for wounds). Clinical Advisor to the Health Quality and Safety Commission on national project to introduce surveillance of hospital-acquired pressure injury prevalence (2016-2018). Contract consultant to Comfort Group on developing an advanced pressure injury prevention product (contract completed). Principal investigator on publicly funded trial (Keratin4VLU) testing a wool-derived keratin dressing. Product provided free of charge by Keraplast Technologies Ltd. Company not involved in conduct or planned analysis of the trial (to be completed September 2019).